Share Price and Basic Stock Data
Last Updated: December 10, 2025, 8:26 pm
| PEG Ratio | 2.10 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
3M India Ltd operates within a diversified landscape, showcasing its ability to adapt and thrive in various sectors. The company reported a sales figure of ₹4,189 Cr for the fiscal year ending March 2024, reflecting a steady upward trajectory from ₹3,336 Cr in FY22. This growth trend is particularly notable when viewed against the backdrop of a challenging economic environment, suggesting that 3M India has effectively leveraged its diverse portfolio. Quarterly sales have shown resilience, with the latest quarter ending June 2024 recording ₹1,047 Cr. This performance indicates a minor dip from the previous quarter, but the overall annual growth remains commendable. The company’s ability to maintain consistent revenue generation, even in fluctuating market conditions, positions it favorably among its peers in the diversified sector.
Profitability and Efficiency Metrics
In terms of profitability, 3M India has demonstrated remarkable efficiency, with an operating profit margin (OPM) reported at 20% for FY24, up from 15% the previous year. This improvement speaks to the company’s operational efficiency and cost management strategies. The net profit for the same period stood at ₹611 Cr, translating to a net profit margin of approximately 13.92%. Such figures indicate a solid profitability profile, especially when considering the company’s high return on equity (ROE) of 30.5% and return on capital employed (ROCE) at 40.5%. However, the price-to-earnings (P/E) ratio of 64.6 suggests that the stock might be viewed as overvalued compared to historical averages. Investors may need to balance the attractive profitability metrics against the premium valuation, which could be a point of contention for value-focused investors.
Balance Sheet Strength and Financial Ratios
The financial health of 3M India appears robust, characterized by a conservative borrowing strategy. With total borrowings of just ₹18 Cr against reserves of ₹2,136 Cr, the company showcases a strong capital foundation, indicating a low debt burden and a comfortable interest coverage ratio of 260.33x. This ratio suggests that 3M India can easily meet its interest obligations, reflecting strong cash flow management. The current ratio stands at a healthy 2.52, which indicates good short-term financial stability. However, the price-to-book value (P/BV) ratio of 16.40x raises questions about market expectations. While the company’s strong fundamentals support this valuation, it could be perceived as high, particularly in a market that may not always reward premium multiples.
Shareholding Pattern and Investor Confidence
Investor confidence in 3M India is underscored by its stable shareholding pattern, with promoters holding a significant 75% stake. This level of control suggests a strong alignment of interests between the management and shareholders. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have maintained relatively modest stakes of 3.43% and 8.12%, respectively, highlighting a cautious approach from institutional players. The public shareholding has remained consistent at around 13.44%, reflecting a stable investor base. This stability can be reassuring for retail investors, as it indicates a lack of significant volatility in ownership that could affect stock performance. However, the declining trend in FII participation from 4.40% in December 2022 to the current 3.43% could hint at a broader market sentiment that warrants attention.
Outlook, Risks, and Final Insight
Looking ahead, 3M India faces both opportunities and challenges. On one hand, its diversified business model positions it well to capitalize on growth in various sectors, particularly in healthcare and consumer products. On the other hand, the elevated P/E ratio could create pressure if the company fails to meet high market expectations. Additionally, the reliance on a narrow base of institutional investors could pose risks if market sentiment shifts. Investors should also consider the broader economic environment, including inflationary pressures and potential regulatory changes, which could impact profitability. Overall, while 3M India exhibits strong fundamentals and a solid market position, the high valuation and evolving investor sentiment necessitate a careful approach for potential investors. Balancing the strengths of the business against these risks will be crucial in determining the stock’s attractiveness in the near term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of 3M India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NESCO Ltd | 8,661 Cr. | 1,223 | 1,639/842 | 20.9 | 397 | 0.53 % | 21.1 % | 15.8 % | 2.00 |
| DCM Shriram Ltd | 18,820 Cr. | 1,207 | 1,502/903 | 26.4 | 463 | 0.75 % | 11.4 % | 8.66 % | 2.00 |
| Balmer Lawrie & Company Ltd | 3,019 Cr. | 177 | 246/147 | 11.4 | 114 | 4.81 % | 14.8 % | 14.0 % | 10.0 |
| 3M India Ltd | 38,960 Cr. | 34,585 | 37,000/25,714 | 63.7 | 1,906 | 0.46 % | 40.5 % | 30.5 % | 10.0 |
| Industry Average | 17,365.00 Cr | 9,298.00 | 30.60 | 720.00 | 1.64% | 21.95% | 17.24% | 6.00 |
Quarterly Result
| Metric | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 744 | 840 | 826 | 926 | 944 | 977 | 993 | 1,046 | 1,050 | 1,040 | 1,006 | 1,095 | 1,047 |
| Expenses | 696 | 748 | 731 | 768 | 827 | 854 | 822 | 852 | 877 | 847 | 827 | 880 | 841 |
| Operating Profit | 48 | 92 | 95 | 158 | 116 | 123 | 171 | 194 | 173 | 192 | 179 | 214 | 205 |
| OPM % | 6% | 11% | 12% | 17% | 12% | 13% | 17% | 19% | 16% | 18% | 18% | 20% | 20% |
| Other Income | 8 | 8 | 8 | 9 | 11 | 35 | 12 | 10 | 15 | 17 | 17 | 30 | 22 |
| Interest | 1 | 1 | 0 | 2 | 1 | 0 | 1 | 6 | 1 | 1 | 1 | 1 | 3 |
| Depreciation | 15 | 13 | 14 | 13 | 14 | 15 | 15 | 14 | 14 | 13 | 13 | 13 | 14 |
| Profit before tax | 41 | 87 | 89 | 151 | 113 | 143 | 167 | 184 | 173 | 196 | 181 | 231 | 211 |
| Tax % | 26% | 26% | 25% | 27% | 26% | 26% | 25% | 26% | 25% | 25% | 25% | 25% | 26% |
| Net Profit | 30 | 64 | 67 | 111 | 84 | 106 | 125 | 136 | 129 | 146 | 135 | 173 | 157 |
| EPS in Rs | 26.72 | 57.01 | 59.24 | 98.46 | 74.80 | 94.30 | 110.79 | 120.48 | 114.70 | 129.70 | 120.05 | 153.44 | 139.50 |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for 3M India Ltd based on the most recent figures (Jun 2024) and their trends compared to the previous period:
- For Sales, as of Jun 2024, the value is 1,047.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,095.00 Cr. (Mar 2024) to 1,047.00 Cr., marking a decrease of 48.00 Cr..
- For Expenses, as of Jun 2024, the value is 841.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 880.00 Cr. (Mar 2024) to 841.00 Cr., marking a decrease of 39.00 Cr..
- For Operating Profit, as of Jun 2024, the value is 205.00 Cr.. The value appears to be declining and may need further review. It has decreased from 214.00 Cr. (Mar 2024) to 205.00 Cr., marking a decrease of 9.00 Cr..
- For OPM %, as of Jun 2024, the value is 20.00%. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00%.
- For Other Income, as of Jun 2024, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2024) to 22.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Jun 2024, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2024) to 3.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Jun 2024, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.00 Cr. (Mar 2024) to 14.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2024, the value is 211.00 Cr.. The value appears to be declining and may need further review. It has decreased from 231.00 Cr. (Mar 2024) to 211.00 Cr., marking a decrease of 20.00 Cr..
- For Tax %, as of Jun 2024, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2024) to 26.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2024, the value is 157.00 Cr.. The value appears to be declining and may need further review. It has decreased from 173.00 Cr. (Mar 2024) to 157.00 Cr., marking a decrease of 16.00 Cr..
- For EPS in Rs, as of Jun 2024, the value is 139.50. The value appears to be declining and may need further review. It has decreased from 153.44 (Mar 2024) to 139.50, marking a decrease of 13.94.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 26, 2024, 2:43 pm
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,710 | 3,017 | 2,987 | 2,605 | 3,336 | 3,959 | 4,189 | 4,186 |
| Expenses | 2,211 | 2,481 | 2,537 | 2,345 | 2,947 | 3,355 | 3,430 | 3,396 |
| Operating Profit | 499 | 536 | 450 | 259 | 389 | 604 | 759 | 791 |
| OPM % | 18% | 18% | 15% | 10% | 12% | 15% | 18% | 19% |
| Other Income | 55 | 60 | 46 | 25 | 37 | 68 | 78 | 86 |
| Interest | 2 | 1 | 4 | 2 | 4 | 7 | 3 | 5 |
| Depreciation | 44 | 44 | 59 | 62 | 55 | 58 | 53 | 53 |
| Profit before tax | 508 | 551 | 433 | 220 | 368 | 607 | 781 | 819 |
| Tax % | 34% | 33% | 26% | 26% | 26% | 26% | 25% | |
| Net Profit | 333 | 366 | 322 | 162 | 272 | 451 | 583 | 611 |
| EPS in Rs | 295.91 | 325.06 | 285.99 | 144.14 | 241.43 | 400.37 | 517.90 | 542.69 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 237% | 132% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 9.91% | -12.02% | -49.69% | 67.90% | 65.81% | 29.27% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.93% | -37.67% | 117.59% | -2.09% | -36.54% |
3M India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2018-2019 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 17% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 53% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 22% |
| Last Year: | 30% |
Last Updated: September 4, 2025, 9:35 pm
Balance Sheet
Last Updated: June 16, 2025, 12:36 pm
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 1,055 | 1,422 | 1,740 | 1,899 | 2,172 | 1,666 | 2,136 |
| Borrowings | 10 | 14 | 42 | 23 | 25 | 27 | 18 |
| Other Liabilities | 1,234 | 672 | 578 | 718 | 798 | 1,010 | 1,083 |
| Total Liabilities | 2,311 | 2,118 | 2,371 | 2,652 | 3,006 | 2,714 | 3,248 |
| Fixed Assets | 303 | 286 | 306 | 266 | 307 | 338 | 332 |
| CWIP | 6 | 12 | 7 | 24 | 23 | 25 | 12 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2,001 | 1,820 | 2,058 | 2,362 | 2,676 | 2,352 | 2,903 |
| Total Assets | 2,311 | 2,118 | 2,371 | 2,652 | 3,006 | 2,714 | 3,248 |
Below is a detailed analysis of the balance sheet data for 3M India Ltd based on the most recent figures (Mar 2024) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2024, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 11.00 Cr..
- For Reserves, as of Mar 2024, the value is 2,136.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,666.00 Cr. (Mar 2023) to 2,136.00 Cr., marking an increase of 470.00 Cr..
- For Borrowings, as of Mar 2024, the value is 18.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 27.00 Cr. (Mar 2023) to 18.00 Cr., marking a decrease of 9.00 Cr..
- For Other Liabilities, as of Mar 2024, the value is 1,083.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,010.00 Cr. (Mar 2023) to 1,083.00 Cr., marking an increase of 73.00 Cr..
- For Total Liabilities, as of Mar 2024, the value is 3,248.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,714.00 Cr. (Mar 2023) to 3,248.00 Cr., marking an increase of 534.00 Cr..
- For Fixed Assets, as of Mar 2024, the value is 332.00 Cr.. The value appears to be declining and may need further review. It has decreased from 338.00 Cr. (Mar 2023) to 332.00 Cr., marking a decrease of 6.00 Cr..
- For CWIP, as of Mar 2024, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Mar 2023) to 12.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Mar 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2024, the value is 2,903.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,352.00 Cr. (Mar 2023) to 2,903.00 Cr., marking an increase of 551.00 Cr..
- For Total Assets, as of Mar 2024, the value is 3,248.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,714.00 Cr. (Mar 2023) to 3,248.00 Cr., marking an increase of 534.00 Cr..
Notably, the Reserves (2,136.00 Cr.) exceed the Borrowings (18.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | 489.00 | 522.00 | 408.00 | 236.00 | 364.00 | 577.00 | 741.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 77 | 71 | 65 | 68 | 58 | 59 | 61 |
| Inventory Days | 96 | 94 | 92 | 104 | 85 | 91 | 77 |
| Days Payable | 93 | 81 | 66 | 114 | 94 | 113 | 120 |
| Cash Conversion Cycle | 79 | 84 | 92 | 58 | 49 | 36 | 19 |
| Working Capital Days | -26 | 54 | 63 | 54 | 38 | 32 | 22 |
| ROCE % | 44% | 27% | 12% | 18% | 31% | 41% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Focused Fund | 75,363 | 2.56 | 222.77 | N/A | N/A | N/A |
| Canara Robeco Large and Mid Cap Fund | 74,821 | 0.84 | 221.17 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 60,000 | 0.43 | 177.36 | N/A | N/A | N/A |
| Bandhan Large & Mid Cap Fund | 59,179 | 1.48 | 174.93 | N/A | N/A | N/A |
| UTI Flexi Cap Fund | 58,803 | 0.67 | 173.82 | 64,500 | 2025-12-08 07:33:47 | -8.83% |
| Nippon India Multi Cap Fund | 56,067 | 0.34 | 165.73 | 45,704 | 2025-08-14 11:47:30 | 22.67% |
| Axis Midcap Fund | 54,955 | 0.51 | 162.45 | 77,057 | 2025-08-14 13:03:48 | -28.68% |
| Nippon India ELSS Tax Saver Fund | 48,600 | 0.93 | 143.66 | 48,600 | 2025-04-22 17:25:44 | 0% |
| UTI MNC Fund | 27,031 | 2.75 | 79.9 | 27,924 | 2025-12-08 07:33:47 | -3.2% |
| ICICI Prudential Business Cycle Fund | 24,489 | 0.48 | 72.39 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 517.90 | 400.37 | 241.43 | 144.14 | 285.99 |
| Diluted EPS (Rs.) | 517.90 | 400.37 | 241.43 | 144.14 | 285.99 |
| Cash EPS (Rs.) | 564.89 | 451.57 | 290.36 | 199.04 | 338.66 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1905.80 | 1489.09 | 1938.35 | 1695.79 | 1554.24 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1905.80 | 1489.09 | 1938.35 | 1695.79 | 1554.24 |
| Revenue From Operations / Share (Rs.) | 3718.89 | 3514.72 | 2961.22 | 2312.30 | 2651.15 |
| PBDIT / Share (Rs.) | 743.33 | 596.88 | 378.47 | 252.30 | 439.91 |
| PBIT / Share (Rs.) | 696.34 | 545.67 | 329.55 | 197.40 | 387.24 |
| PBT / Share (Rs.) | 693.48 | 539.22 | 326.24 | 195.22 | 383.99 |
| Net Profit / Share (Rs.) | 517.90 | 400.37 | 241.43 | 144.14 | 285.99 |
| NP After MI And SOA / Share (Rs.) | 517.90 | 400.37 | 241.43 | 144.14 | 285.99 |
| PBDIT Margin (%) | 19.98 | 16.98 | 12.78 | 10.91 | 16.59 |
| PBIT Margin (%) | 18.72 | 15.52 | 11.12 | 8.53 | 14.60 |
| PBT Margin (%) | 18.64 | 15.34 | 11.01 | 8.44 | 14.48 |
| Net Profit Margin (%) | 13.92 | 11.39 | 8.15 | 6.23 | 10.78 |
| NP After MI And SOA Margin (%) | 13.92 | 11.39 | 8.15 | 6.23 | 10.78 |
| Return on Networth / Equity (%) | 27.17 | 26.88 | 12.45 | 8.49 | 18.40 |
| Return on Capital Employeed (%) | 35.83 | 35.44 | 16.53 | 11.32 | 24.23 |
| Return On Assets (%) | 17.96 | 16.61 | 9.04 | 6.12 | 13.58 |
| Asset Turnover Ratio (%) | 1.41 | 1.26 | 1.04 | 0.91 | 1.16 |
| Current Ratio (X) | 2.52 | 2.17 | 3.20 | 3.10 | 3.27 |
| Quick Ratio (X) | 2.02 | 1.55 | 2.56 | 2.44 | 2.50 |
| Inventory Turnover Ratio (X) | 2.80 | 2.96 | 2.86 | 2.16 | 2.50 |
| Dividend Payout Ratio (NP) (%) | 19.30 | 212.30 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 17.70 | 188.23 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 80.70 | -112.30 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 82.30 | -88.23 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 260.33 | 92.48 | 114.60 | 115.82 | 135.32 |
| Interest Coverage Ratio (Post Tax) (X) | 182.38 | 63.04 | 74.10 | 67.17 | 88.97 |
| Enterprise Value (Cr.) | 33848.64 | 25120.84 | 20825.74 | 33001.61 | 20527.25 |
| EV / Net Operating Revenue (X) | 8.08 | 6.34 | 6.24 | 12.67 | 6.87 |
| EV / EBITDA (X) | 40.42 | 37.36 | 48.85 | 116.11 | 41.42 |
| MarketCap / Net Operating Revenue (X) | 8.40 | 6.55 | 6.64 | 13.08 | 7.13 |
| Retention Ratios (%) | 80.69 | -112.30 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 16.40 | 15.45 | 10.15 | 17.83 | 12.17 |
| Price / Net Operating Revenue (X) | 8.40 | 6.55 | 6.64 | 13.08 | 7.13 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
After reviewing the key financial ratios for 3M India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 517.90. This value is within the healthy range. It has increased from 400.37 (Mar 23) to 517.90, marking an increase of 117.53.
- For Diluted EPS (Rs.), as of Mar 24, the value is 517.90. This value is within the healthy range. It has increased from 400.37 (Mar 23) to 517.90, marking an increase of 117.53.
- For Cash EPS (Rs.), as of Mar 24, the value is 564.89. This value is within the healthy range. It has increased from 451.57 (Mar 23) to 564.89, marking an increase of 113.32.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,905.80. It has increased from 1,489.09 (Mar 23) to 1,905.80, marking an increase of 416.71.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,905.80. It has increased from 1,489.09 (Mar 23) to 1,905.80, marking an increase of 416.71.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 3,718.89. It has increased from 3,514.72 (Mar 23) to 3,718.89, marking an increase of 204.17.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 743.33. This value is within the healthy range. It has increased from 596.88 (Mar 23) to 743.33, marking an increase of 146.45.
- For PBIT / Share (Rs.), as of Mar 24, the value is 696.34. This value is within the healthy range. It has increased from 545.67 (Mar 23) to 696.34, marking an increase of 150.67.
- For PBT / Share (Rs.), as of Mar 24, the value is 693.48. This value is within the healthy range. It has increased from 539.22 (Mar 23) to 693.48, marking an increase of 154.26.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 517.90. This value is within the healthy range. It has increased from 400.37 (Mar 23) to 517.90, marking an increase of 117.53.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 517.90. This value is within the healthy range. It has increased from 400.37 (Mar 23) to 517.90, marking an increase of 117.53.
- For PBDIT Margin (%), as of Mar 24, the value is 19.98. This value is within the healthy range. It has increased from 16.98 (Mar 23) to 19.98, marking an increase of 3.00.
- For PBIT Margin (%), as of Mar 24, the value is 18.72. This value is within the healthy range. It has increased from 15.52 (Mar 23) to 18.72, marking an increase of 3.20.
- For PBT Margin (%), as of Mar 24, the value is 18.64. This value is within the healthy range. It has increased from 15.34 (Mar 23) to 18.64, marking an increase of 3.30.
- For Net Profit Margin (%), as of Mar 24, the value is 13.92. This value exceeds the healthy maximum of 10. It has increased from 11.39 (Mar 23) to 13.92, marking an increase of 2.53.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 13.92. This value is within the healthy range. It has increased from 11.39 (Mar 23) to 13.92, marking an increase of 2.53.
- For Return on Networth / Equity (%), as of Mar 24, the value is 27.17. This value is within the healthy range. It has increased from 26.88 (Mar 23) to 27.17, marking an increase of 0.29.
- For Return on Capital Employeed (%), as of Mar 24, the value is 35.83. This value is within the healthy range. It has increased from 35.44 (Mar 23) to 35.83, marking an increase of 0.39.
- For Return On Assets (%), as of Mar 24, the value is 17.96. This value is within the healthy range. It has increased from 16.61 (Mar 23) to 17.96, marking an increase of 1.35.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.41. It has increased from 1.26 (Mar 23) to 1.41, marking an increase of 0.15.
- For Current Ratio (X), as of Mar 24, the value is 2.52. This value is within the healthy range. It has increased from 2.17 (Mar 23) to 2.52, marking an increase of 0.35.
- For Quick Ratio (X), as of Mar 24, the value is 2.02. This value exceeds the healthy maximum of 2. It has increased from 1.55 (Mar 23) to 2.02, marking an increase of 0.47.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.80. This value is below the healthy minimum of 4. It has decreased from 2.96 (Mar 23) to 2.80, marking a decrease of 0.16.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 19.30. This value is below the healthy minimum of 20. It has decreased from 212.30 (Mar 23) to 19.30, marking a decrease of 193.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 17.70. This value is below the healthy minimum of 20. It has decreased from 188.23 (Mar 23) to 17.70, marking a decrease of 170.53.
- For Earning Retention Ratio (%), as of Mar 24, the value is 80.70. This value exceeds the healthy maximum of 70. It has increased from -112.30 (Mar 23) to 80.70, marking an increase of 193.00.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 82.30. This value exceeds the healthy maximum of 70. It has increased from -88.23 (Mar 23) to 82.30, marking an increase of 170.53.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 260.33. This value is within the healthy range. It has increased from 92.48 (Mar 23) to 260.33, marking an increase of 167.85.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 182.38. This value is within the healthy range. It has increased from 63.04 (Mar 23) to 182.38, marking an increase of 119.34.
- For Enterprise Value (Cr.), as of Mar 24, the value is 33,848.64. It has increased from 25,120.84 (Mar 23) to 33,848.64, marking an increase of 8,727.80.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 8.08. This value exceeds the healthy maximum of 3. It has increased from 6.34 (Mar 23) to 8.08, marking an increase of 1.74.
- For EV / EBITDA (X), as of Mar 24, the value is 40.42. This value exceeds the healthy maximum of 15. It has increased from 37.36 (Mar 23) to 40.42, marking an increase of 3.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 8.40. This value exceeds the healthy maximum of 3. It has increased from 6.55 (Mar 23) to 8.40, marking an increase of 1.85.
- For Retention Ratios (%), as of Mar 24, the value is 80.69. This value exceeds the healthy maximum of 70. It has increased from -112.30 (Mar 23) to 80.69, marking an increase of 192.99.
- For Price / BV (X), as of Mar 24, the value is 16.40. This value exceeds the healthy maximum of 3. It has increased from 15.45 (Mar 23) to 16.40, marking an increase of 0.95.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 8.40. This value exceeds the healthy maximum of 3. It has increased from 6.55 (Mar 23) to 8.40, marking an increase of 1.85.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 3M India Ltd:
- Net Profit Margin: 13.92%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 35.83% (Industry Average ROCE: 21.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 27.17% (Industry Average ROE: 17.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 182.38
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.02
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 63.7 (Industry average Stock P/E: 30.6)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.92%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Diversified | Plot No 48-51, Electronic City, Bengaluru Karnataka 560100 | investorhelpdesk.in@mmm.com http://www.3m.com/in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Ramadurai | Managing Director |
| Ms. Radhika Rajan | Chairperson & Independent Director |
| Mr. N V Sivakumar | Independent Director |
| Ms. Kong Sau Wai Elizabeth | Non Executive Director |
| Ms. Jung Hyun Kim | Non Executive Director |
| Mr. Jayanand V Kaginalkar | Whole Time Director |
FAQ
What is the intrinsic value of 3M India Ltd?
3M India Ltd's intrinsic value (as of 10 December 2025) is 29760.85 which is 13.95% lower the current market price of 34,585.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 38,960 Cr. market cap, FY2025-2026 high/low of 37,000/25,714, reserves of ₹2,136 Cr, and liabilities of 3,248 Cr.
What is the Market Cap of 3M India Ltd?
The Market Cap of 3M India Ltd is 38,960 Cr..
What is the current Stock Price of 3M India Ltd as on 10 December 2025?
The current stock price of 3M India Ltd as on 10 December 2025 is 34,585.
What is the High / Low of 3M India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of 3M India Ltd stocks is 37,000/25,714.
What is the Stock P/E of 3M India Ltd?
The Stock P/E of 3M India Ltd is 63.7.
What is the Book Value of 3M India Ltd?
The Book Value of 3M India Ltd is 1,906.
What is the Dividend Yield of 3M India Ltd?
The Dividend Yield of 3M India Ltd is 0.46 %.
What is the ROCE of 3M India Ltd?
The ROCE of 3M India Ltd is 40.5 %.
What is the ROE of 3M India Ltd?
The ROE of 3M India Ltd is 30.5 %.
What is the Face Value of 3M India Ltd?
The Face Value of 3M India Ltd is 10.0.